- Home
- REE vs NTRB Comparison
REE vs NTRB Comparison
Compare REE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- NTRB
- Stock Information
- Founded
- REE 2011
- NTRB 2016
- Country
- REE Israel
- NTRB United States
- Employees
- REE N/A
- NTRB N/A
- Industry
- REE Auto Manufacturing
- NTRB Industrial Specialties
- Sector
- REE Consumer Discretionary
- NTRB Health Care
- Exchange
- REE Nasdaq
- NTRB Nasdaq
- Market Cap
- REE 52.8M
- NTRB 49.2M
- IPO Year
- REE N/A
- NTRB N/A
- Fundamental
- Price
- REE $6.18
- NTRB $5.08
- Analyst Decision
- REE Buy
- NTRB
- Analyst Count
- REE 4
- NTRB 0
- Target Price
- REE $9.25
- NTRB N/A
- AVG Volume (30 Days)
- REE 767.5K
- NTRB 29.8K
- Earning Date
- REE 09-26-2024
- NTRB 09-03-2024
- Dividend Yield
- REE N/A
- NTRB N/A
- EPS Growth
- REE N/A
- NTRB N/A
- EPS
- REE N/A
- NTRB N/A
- Revenue
- REE $1,768,000.00
- NTRB $1,803,816.00
- Revenue This Year
- REE $31,642.54
- NTRB N/A
- Revenue Next Year
- REE N/A
- NTRB N/A
- P/E Ratio
- REE N/A
- NTRB N/A
- Revenue Growth
- REE N/A
- NTRB N/A
- 52 Week Low
- REE $2.30
- NTRB $1.53
- 52 Week High
- REE $8.43
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- REE 76.84
- NTRB 51.44
- Support Level
- REE $2.91
- NTRB $4.23
- Resistance Level
- REE $3.68
- NTRB $4.72
- Average True Range (ATR)
- REE 0.50
- NTRB 0.58
- MACD
- REE 0.29
- NTRB 0.15
- Stochastic Oscillator
- REE 85.16
- NTRB 59.57
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.